(Hartford, CT) — Attorney General William Tong today announced that Genco Lab, LLC and its owners and officers, Paul Conroy, Tricia Conroy, and Charles Orefice, have entered into a civil settlement agreement with the federal and state governments and agreed to pay more than $1.2 million to settle allegations that they submitted false and fraudulent claims to government health care programs for medically unnecessary urine drug tests.
Genco Lab is a reference laboratory with offices in Branford. Paul Conroy is the majority owner, Charles Orefice is a part owner, and Tricia Conroy is the Chief Operating Officer.
The government alleges that Genco and its owners and officers violated the federal and state False Claims Acts in two ways. First, they submitted claims for medically unnecessary urine drug tests for Medicare and Connecticut Medicaid beneficiaries residing in sobor homes solely for the purposes of “residential monitoring,” which was explicitly prohibited. Second, they submitted claims for medically unnecessary duplicative urine drug testing.
There are several different types of urine drug testing. A screening test, also called a “presumptive” test, detects the presence or absence of certain classes of drugs, such as opiates, cocaine, and amphetamines. A screening test does not measure the specific amount of the drug present in the patient’s urine sample, but provides only a positive or a negative result, indicating the presence or absence of a...
TOKYO: False claims that Japan's new prime minister has created a ministry for "mass deportations" have been widely spread online, as immigration misinformation swirls after a "Japanese first" par...